CEG: Post-Earnings Consolidation – Premium Re-Entry SetupConstellation Energy CorporationBATS:CEGshortermtraderIdea: Long CEG (Constellation Energy) Entry: $279.00 **Stop Loss:** $249.00 Take Profit: $351.00 **Risk/Reward:** ~1:2.1 (Risk $30 / Reward $72) Timeframe: Position / Swing Trading (Weeks to Months) The Setup Constellation Energy delivered a strong Q2 2026 earnings beat on August 6, reporting adjusted operating earnings of $2.55 per share, up 33.5% year-over-year and beating the $2.41 consensus by 5.8%. The company also raised full-year guidance to $11.50–$12.50 per share, lifting the midpoint by $0.50 from the previous $11–$12 range. Yet the stock has pulled back from post-earnings highs near $290 to current levels around $275–$280 — a healthy consolidation that offers a compelling re-entry opportunity. The Fundamentals Q2 results were driven by three key factors: the Calpine acquisition contribution, higher PJM capacity prices, and strong commercial execution. The Calpine integration is progressing smoothly — the company recently sold the Brazos Valley gas plant in Texas to LS Power for $860 million, satisfying the final DOJ divestiture requirement tied to the acquisition. Nuclear contract momentum has been exceptional. Constellation signed 920 MW in new long-term power purchase agreements with investment-grade customers, with an average contract duration of 18.5 years, starting between 2029 and 2031. This includes a 176 MW agreement with Walmart that will fund a 30 MW expansion at Dresden, adding to prior 20-year agreements with Microsoft and Meta Platforms. The Crane Clean Energy Center restart is progressing, with the FERC approving the interconnection rights transfer and the NRC approving the fuel license amendment. The 835 MW plant is expected to restart in 2027 to fulfill the Microsoft contract. Management now projects 20% CAGR base earnings growth through 2029, supported by strong clean energy demand and a robust contract pipeline. For 2026, the company raised guidance to $11.50–$12.50 per share. Analyst Backing Wall Street remains overwhelmingly bullish on CEG. According to 23 analysts polled by S&P Global, the consensus rating is Buy with an average price target of $349.96, implying 29% upside. Eleven analysts on eToro rate it Strong Buy with a target of $357.55, while MarketBeat's 23 analysts average $360.45. The target range extends from $277 on the low end to $462 on the high end, with our $351 take profit sitting comfortably within this range. Recent analyst moves include BMO Capital lowering its target from $390 to $376 while maintaining Outperform, BofA lowering from $361 to $341 while maintaining Buy, Evercore ISI maintaining Buy with a $380 target, and Scotiabank maintaining Buy with a $441 target. The rating distribution shows 17 Strong Buy, 5 Buy, and 3 Hold — zero sell ratings. Technical Setup The stock has been consolidating after a strong post-earnings recovery. The 52-week range spans $228.63 to $412.70, with the current price around $279, up from the August 6 close of $261. The stock remains down roughly 24.8% year-to-date and trades 33.3% below its 52-week high, offering a significant margin of safety for a mean reversion trade. Key support sits at $268 (recent low), followed by $246.98 as a strong structural floor. Resistance lies at $290 (post-earnings high), with the analyst target zone of $325–$350 as the next major level. The RSI(14) sits near 44.5, indicating oversold territory that historically precedes reversals. Entry at $279 offers a clean entry above recent support and near the breakout level from the post-earnings consolidation. Stop at $249 sits below the $246.98 support zone and the 52-week low range, providing structural protection. Target at $351 aligns with the average analyst target and represents a retracement toward the upper end of the 52-week range. The Catalyst The Q2 earnings beat and guidance raise on August 6 were the primary catalysts. The post-earnings pullback represents classic profit-taking — not a rejection of the underlying thesis. Upcoming catalysts include the dividend payment of $0.43 per share with an ex-dividend date of August 18, continued progress on the Crane Clean Energy Center restart toward 2027, potential further nuclear contract announcements given the strong pipeline, and possible additional analyst upgrades as the Street fully digests the Q2 results. Key Risks Valuation is near GF Value estimates — limited margin of safety. Cost pressures remain significant, with operating expenses rising 34.5% year-over-year due to the Calpine integration. Nuclear output declined to 44,160 GWh from 45,170 GWh, and the capacity factor fell slightly. As a merchant generator, CEG faces regulatory risk from potential policy changes. A break below $246 would invalidate the support thesis. Conclusion Constellation Energy offers a high-probability setup on three pillars. Fundamentally, the company delivered a Q2 earnings beat with 33.5% EPS growth, raised guidance to $11.50–$12.50, signed 920 MW in new nuclear contracts, and projects 20% CAGR earnings growth through 2029. Technically, the stock is consolidating above support and trading 33% below its 52-week high, with oversold RSI levels that have preceded reversals. Institutionally, 23 analysts maintain a Buy consensus with an average target of $349.96, zero sell ratings, and recent upgrades from Evercore and Scotiabank. Entry $279, Stop $249, Target $351 — a clean, risk-defined setup with favorable 1:2.1 asymmetry. ⚠️ Disclaimer: This is a personal trading idea based on technical and fundamental analysis, not financial advice. Trading involves substantial risk of loss. Past performance is not indicative of future results. Always conduct your own research and risk assessment, and never risk more than you can afford to lose. Manage your position size appropriately.